Tissue Repair
BPC-157
A pentadecapeptide studied in tissue repair investigation.
- Molecular weight
- 1419.5 g/mol
- Half-life
- ~30 minutes (oral, rodent)
- Receptor targets
- VEGF, NO synthase, GH receptor crosstalk
RESEARCH USE ONLY · LYOPHILIZED PEPTIDES · NORTH CAROLINA
Bench-grade compounds. Cited research. Verified COAs.
Kodiac biolabs sources, lyophilizes, and fulfills research peptides for serious investigators. Every batch is HPLC-verified by our supplier with documentation published in full. Independent Janoshik third-party verification is in progress. Every order ships cold-chain.
Kodiac exists because research compounds deserve laboratory rigor, not gray-market shortcuts. We source from disciplined manufacturers, verify every batch through independent HPLC analysis, and document every lot with a publicly retrievable certificate of analysis. The work the science requires is the work we do.
≥98% vendor HPLC purity · Janoshik verification pending · Cold-chain shipped
Nootropic of the week
COGNITIVE / Week 1 of 3
-
Adamax
A next-generation ACTH(4-10) analog engineered from Semax with N-terminal acetylation and C-terminal adamantylglycine amidation, designed to extend plasma half-life and central nervous system bioavailability while preserving the parent compound’s neurotrophic, neuroprotective, and monoaminergic pharmacology.
Tissue Repair
TB-500
A synthetic fragment of thymosin beta-4 studied in tissue repair contexts.
- Molecular weight
- 889.0 g/mol
- Half-life
- ~2-3 hours (rodent literature)
- Receptor targets
- Actin-binding domain, VEGF
Growth Hormone Axis
Ipamorelin
A selective GHRP studied for ghrelin receptor modulation.
- Molecular weight
- 711.85 g/mol
- Half-life
- ~2 hours
- Receptor targets
- Ghrelin receptor (GHS-R1a)
Growth Hormone Axis
CJC-1295 nDAC
A GHRH analog studied without DAC modification.
- Molecular weight
- 3367.9 g/mol
- Half-life
- ~30 minutes
- Receptor targets
- GHRH receptor
Longevity
Epithalon
A tetrapeptide bioregulator studied for telomerase activity.
- Molecular weight
- 390.4 g/mol
- Half-life
- ~30 minutes
- Receptor targets
- Telomerase, pineal regulation
We started Kodiac because the research-compound market was full of products and empty of proof.
Most vendors photograph a vial, write a tagline, and call it credibility. We took the longer route. Bulk peptide sourced from a disciplined manufacturer with full vendor HPLC, mass spectrometry, and 1H NMR documentation per lot. Independent Janoshik third-party verification is in progress and will be published alongside the existing reports as it completes. Every lot is documented, scanned, and posted publicly so investigators can verify before they buy.
That is the entire model. Source carefully. Verify independently. Document everything. Ship cold. Disclose the rest.
SOURCEDVERIFIEDDOCUMENTED
LATEST MONOGRAPHS
Read the research before you order.
-
MONOGRAPH
Adamax
Read: AdamaxA next-generation ACTH(4-10) analog engineered from Semax with N-terminal acetylation and C-terminal adamantylglycine amidation, designed to extend plasma half-life and central nervous system bioavailability while preserving the parent compound’s neurotrophic, neuroprotective, and monoaminergic pharmacology.
-
MONOGRAPH
Alfaxalone
Read: AlfaxaloneA synthetic pregnane neurosteroid originally developed by Glaxo as the active component of the intravenous anesthetic Althesin, reformulated in cyclodextrin carriers for veterinary registration and under active clinical investigation for human anesthesia with emerging evidence for neuroprotection and postoperative cognitive preservation.
-
MONOGRAPH
Amphetamine
Read: AmphetamineA racemic or enantiopure phenylpropylamine first synthesized in 1887, developed as the prototypical indirect sympathomimetic stimulant, and established as a first-line pharmacotherapy for attention-deficit/hyperactivity disorder and narcolepsy through potent reversal of monoamine transporter function and vesicular monoamine redistribution.
New batches. New monographs. Quarterly.
Write to us from the contact page to join the list.